GlassScriptPhysician profile
Keith W Blackman
NPI 1477532885
$268.41
in general payments reported to CMS, 2019-2025
9 companies · $23.70 in 2025
The $23.70 reported for 2025 was less than what a typical Public Health & General Preventive Medicine provider received nationally (typical 2025 total: $95.27).
See the full distribution for Public Health & General Preventive Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.35 · 2022: $61.99 · 2023: $128 · 2025: $23.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $61.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.86 | 2023 | |
| Genentech USA, INC. | $54.35 | 2019 | |
| Envista Holdings Corporation | $23.70 | 2025 | Spark |
| Exact Sciences Corporation | $15.29 | 2023 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $15.20 | 2023 | |
| Ironwood Pharmaceuticals, INC | $14.03 | 2023 | Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.84 | 2023 | Xifaxan, Trulance |
| Lilly USA, LLC | $13.15 | 2023 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Blackman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.